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Abstract: Preprocessing of transcriptomics data plays a pivotal role in the development of
toxicogenomics-driven tools for chemical toxicity assessment. The generation and exploitation
of large volumes of molecular profiles, following an appropriate experimental design, allows the
employment of toxicogenomics (TGx) approaches for a thorough characterisation of the mechanism
of action (MOA) of different compounds. To date, a plethora of data preprocessing methodologies
have been suggested. However, in most cases, building the optimal analytical workflow is not
straightforward. A careful selection of the right tools must be carried out, since it will affect the
downstream analyses and modelling approaches. Transcriptomics data preprocessing spans across
multiple steps such as quality check, filtering, normalization, batch effect detection and correction.
Currently, there is a lack of standard guidelines for data preprocessing in the TGx field. Defining the
optimal tools and procedures to be employed in the transcriptomics data preprocessing will lead
to the generation of homogeneous and unbiased data, allowing the development of more reliable,
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robust and accurate predictive models. In this review, we outline methods for the preprocessing
of three main transcriptomic technologies including microarray, bulk RNA-Sequencing (RNA-Seq),
and single cell RNA-Sequencing (scRNA-Seq). Moreover, we discuss the most common methods for
the identification of differentially expressed genes and to perform a functional enrichment analysis.
This review is the second part of a three-article series on Transcriptomics in Toxicogenomics.
Keywords: toxicogenomics; transcriptomics; RNA-Seq; scRNA-Seq; microarray; data preprocessing;
quality check; normalization; batch effect; differential expression.
1. Introduction
The development of omic sciences gave unprecedented insights into physiological and pathological
mechanisms at a molecular level, arguably in almost all the areas of life sciences, including toxicology [1].
The technological advances in the post-genomic era allowed the rise of toxicogenomics as an effective
complementary approach in modern toxicology. Among all, the most employed omics technique
in toxicology is undoubtedly transcriptomics, which allows the deep profiling of the transcriptome
of a number of tissues and cell lines [2]. The hybridization-based technologies first, such as DNA
microarrays, and the sequencing-based approaches, like RNA-Sequencing (RNA-Seq) later, conquered
the market in the last two decades, achieving, nowadays, the resolution of the single cell.
The production of large data sets from transcriptomics experiments encouraged the birth of
high-throughput studies, led by big consortia, aimed at generating public repositories that contain
humongous amounts of gene expression data, which have been made available to the scientific
community [3–9]. These rich sources of data are aimed not only to the identification of biomarkers
of toxicity, but also to determine the link between their expression signatures to the toxicological
phenotype of the organism for a particular exposure or dose and at a particular time, in order to satisfy
the principle of “phenotypic anchoring” [1].
However, to carry out a rigorous analysis and obtain reliable results, a correct analytical procedure
should be employed. Despite the well defined pipelines for generic transcriptome data analysis have
been already designed [10], well established guidelines for the analysis of gene expression in a
toxicogenomics setting have not been formulated. In fact, even a single transcriptomics experiment
produces massive amounts of data, whose preprocessing and management are not straightforward [11].
Every transcriptomics experimental scenario could potentially have different optimal methods for
transcript quantification, normalization, detection of surrogate variables and, ultimately, differential
expression analysis. In addition, quality control checks should be applied pertinently at different stages
of the analysis to ensure the reliability of the results. For all of the steps, a balance between the most
updated and widely employed methods should be achieved. Moreover, keeping track of the statistical
methods employed in the data preprocessing improves the reproducibility and the transparency of the
analyses and, therefore, makes the data interpretation trustworthy [12,13].
In this work, we outline current standards, available resources and good practices for the
bioinformatics analysis of transcriptomics data in toxicogenomics, generated from both microarray
and RNA-Seq technologies. We discuss the new opportunities and challenges provided by single-cell
RNA-seq and the analytical differences with the bulk RNA-Seq. Finally, we cover the most used
algorithms for differential expression analysis and to perform a robust functional annotation, in order
to elucidate the toxicity-related cellular processes.
2. Data Preprocessing
2.1. Microarray Experiments
The hypothesis underlying a microarray analysis is that relative gene expression levels are
represented as fluorescence intensities. Indeed, microarray experiments allow investigating relationships
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between biological samples based on expression patterns. Thus, biologically relevant patterns are
identified by investigating each gene expression ratio between different conditions [14]. However, this
comparison cannot be performed before a number of transformations are carried out on the data to
eliminate low-intensity measurements, to adjust the intensity values to perform robust comparisons
and to identify differentially expressed genes.
The current standard of a microarray data preprocessing pipeline is shown in Figure 1 and
comprises the following steps: quality check, probe prefiltering, normalization, batch effect and
surrogate variables estimation and correction [15]. A complete list of all the methods and R packages
used to implement this pipeline is shown in Table S1.

















Figure 1. Data preprocessing schema for microarray. The brown box indicates the input of the pipeline.
The green box indicates the output of the pipeline. The blue boxes show the intermediate steps of the
pipeline and above or below the boxes are listed the software/packages employed in the step.
2.2. Quality Check
The gene expression patterns measured from microarray experiments can be significantly affected
by different sources of systematic and random errors that may occur at different levels of the
experiment [16]. For example, an inappropriate experimental design may affect the data set as a
whole; poor probe design or probe misannotation will affect the readout of a particular probe; sample
mislabelling or inappropriate sample treatment may result in individual outlier arrays. Checking the
quality of the samples before performing any kind of analysis is crucial. Quality check (QC) methods
aim at homogenizing the shape of gene expression distributions and to increase the robustness of
probe intensity measures across different samples. A particular care in the QC of microarray data
should be posed to the detection of RNA degradation signals. A commonly employed procedure of
quality check, which takes into account the RNA degradation level, is to compute the Normalized
Unscaled Standard Error (NUSE) [17], the Relative Log Expression (RLE) [17] and the slope of the
RNA degradation curve (RNADeg) [18]. The samples outlierness can be computed by investigating
the distributions of the values of the three metrics. A sample could be considered an outlier by using a
consensus on the three scores, giving particular relevance to the RNADeg value. The distributions of
the values of these three metrics can be investigated by means of boxplot and the sample outlierness
is evaluated for each measure based on the data distribution. Eventually, a concordance outlierness
score was computed across the three metrics. In particular, a sample was removed from the analysis if
considered an outlier in at least two out of three metrics, one of them being the RNA degradation curve.
Overall, several quality check methods have been proposed and often based on visual inspection of
the data [19]. See Table S2 for a full list of QC plots and libraries employed in this step.
Another invaluable form of quality assurance that is specific for toxicological applications, as well
as assessing the effects of engineered nanomaterials (ENMs) on RNA levels, is the use of spike-in
probes, in order to account for variation between the arrays. Typically, spike-in kits consist of a
mixture of multiple positive control transcripts at known concentrations which, for instance, anneal to
complementary probes on the microarray. Therefore, the design of the assay is able to control for any
abnormalities in the labelling and hybridisation procedure including the potential interference by
ENMs, which may occur on fluorescent dyes in use [20].
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2.3. Probe Prefiltering
Microarray data commonly show a large number of probes in the background intensity range.
Usually, these probes’ intensities do not show a marked variability across arrays. Hence, they combine
a low variance with low intensity. Thus, in many cases, they might be detected as differentially
expressed, although they are barely above the “detection” limit and are not very informative in general.
For these reasons, such probes are filtered out prior to further preprocessing steps.
2.4. Normalization
Normalization plays an important role in the microarray preprocessing since it allows to adjust
the individual hybridization intensities in order to perform meaningful biological comparisons [14].
In this context, different methods have been proposed [14,21,22] that adjust the distributions of the
values. A common strategy is the scale normalization approach [21,23] that forces the different
samples to have the same median absolute deviation. This strategy does not consider that the shape of
the distributions of the different arrays may vary between each other, thus it might be less efficient.
A different approach normalizes the samples by adjusting their variability, such as the Locally Weighted
Scatterplot Smoothing (LOWESS) algorithm [21,24]. It has been proposed in order to remove the bias
present in the data which most commonly shows a deviation from zero for low-intensity spots.
Furthermore, one commonly used adjustment approach is the quantile normalization [25,26] that
assumes the statistical distribution of each sample to be the same, hence applying a scaling approach
that also accounts for the variability.
2.5. Batch Effect Estimation and Correction
Gene expression data coming from microarray experiments can be affected by non-biological
variables. The variability in the gene expression values due to these types of variables is known as
batch effect. Batch effects can arise for multiple reasons, such as ambient conditions during the sample
preparation and handling, amplification, labelling, hybridization protocol, different sites/laboratories
in which the experiments are performed, different chip or platform types and different scanners [27].
These batches have a detrimental effect on the quality of the data and can ultimately lead to incorrect
results [28].
A fundamental step in the analysis is to attenuate the effects associated with batch variables
while retaining the variation associated with biological variables. As previously discussed, to be
able to properly correct the batch effects, the experimental design, including sample randomization
and proper metadata annotation, needs to be carefully considered. Batch estimation and correction
can be performed by using the surrogate variable analysis (SVA) R library [29]. Known biological
(e.g., treatment, disease status, age, tissue) and technical (e.g., dye, array) variables are in general
provided by the user in the phenotypic information, while unknown sources of variation can also be
identified through the surrogate variable analysis [29]. The impact of the technical variables on the
expression values can be identified by means of the prince plot (Figure 2A), that shows the correlation
between the variables and the principal components of the expression matrix. In fact, the prince plot is
a visualization of the output of Principal Components Analysis (PCA), which is a popular and powerful
method to quantify the effect of batch variables, as well as to reveal the presence of unaddressed
sources of batch behaviour in the data [30]. Moreover, the correlation between both biological and
technical variables can be visually evaluated by the confounding plot (Figure 2B). This information is
used to identify batch variables as known technical or surrogate variables which are associated with
strong sources of variation and are not correlated with biological variables of interest.
These identified batch variables can be corrected to remove technical noise from the data. The R
ComBat function [31], from the SVA package, can be used to remove the known batch variables and
the estimated surrogate variables when not confounded with the variables of interest. Briefly, ComBat
employs an empirical Bayes approach to estimate systemic batch biases affecting large sets of genes.
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The batch correction is carried out by specifying the variable of interest, any biological covariates, and a
set of known batches or surrogate variables (obtained from the SVA, as described above). Since each
run of ComBat function can only address the effect of one batch variable, any additional variables that
cause known batch effects can be added directly to the linear model implemented for the differential
expression analysis. When using SVA, it is important to have in mind that it will clear out the effect of
any biological information that is not addressed by the known phenotype-related variables, such as
phenotypic subgroups, that might be of interest [24]. For this reason, one can opt to use another linear
modelling solution, for example the limma R package, that also permits the investigation of the effect
of the covariates that are included in the model [32].
Figure 2. Panel A—Prince plot showing the association between the technical variables and the
principal components. The text and the background color in each cell represent the association p-value.
The row label underlined with solid blue line represents the variable of interest. The row labels
underlined with dotted purple line represent other sources of high variation. Panel B—Confounding
plot, representing the correlation among the technical variables. The row label underlined with solid
blue line represents the variable of interest. The green squares represent the variables confounded
with the variable of interest or other batch variables. The row labels circled by red outline are batch
variables suitable for correction.
2.6. Probe Annotation
Accurate mapping of the microarray probes to genomic elements, such as genes or regulatory
regions, is essential to generate reliable biological findings. However, the manufacturers of microarray
platforms typically provide incomplete and/or outdated probe annotations, which often rely on
older reference genome and transcriptome versions that differ substantially from up-to-date sequence
databases [33]. To deal with these drawbacks, annotation pipeline tools have been proposed such as
Re-annotator30. Annotations can also address conversion to different types of gene identifiers directly,
such as Ensembl gene ID or Entrez gene ID. Furthermore, databases containing up-to-date annotation
mapping are available, such as the Brainarray website (http://brainarray.mbni.med.umich.edu) from
which the custom CDF file can be downloaded and used in combination with Bioconductor libraries to
annotate Affymetrix microarray data.
2.7. Tools for Microarray Data Analysis
A huge collection of computational tools is available, both on CRAN and Bioconductor [34],
to process omics data. However, the use of these tools requires a deep understanding of the statistics
and methodological implementation. The integration of these tools as a unique workflow, requires
proficiency in computer programming languages. Thus, a set of tools with graphical interface were
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developed to facilitate the analysis for the user such as AGA [35], shinyMethyl, MeV [36], O-miner [37],
Chipster [38], Babelomics [39] and eUTOPIA [40]. Among all, eUTOPIA is the only one that implements
all the steps of the microarray data preprocessing. In particular, all of the aforementioned tools
implement the normalization steps, but some of them do not implement the quality check and probe
filtering steps, and, more importantly, eUTOPIA and Chipster also allows to perform the batch effect
estimation and correction, that is of extreme importance for microarray analysis because it can help to
isolate technical noise from the biological signal.
3. RNA Sequencing
The state of the art of a typical RNA-Seq preprocessing pipeline is shown in Figure 3 and comprises
the following steps: quality check, reads alignment, raw counts extraction, counts normalization and
filtering and batch effect estimation and correction [10]. A complete list of all the methods and R
packages used to implement this pipeline is shown in Table S3.

















Figure 3. Data preprocessing schema for RNA-Seq. The brown box indicates the input of the pipeline.
The green box indicates the output of the pipeline. The blue boxes show the intermediate steps of the
pipeline and above or below the boxes are shown the software/packages employed in the step.
3.1. Quality Check
Similarly to microarray experiments, deep sequencing procedures may suffer from certain biases,
which should be detected and corrected through an accurate quality check prior to subsequent analyses.
From an experimental point of view, a pre-analitical check of the quality of the extracted RNA is
necessary. There is currently no consensus to establish whether a sample is unusable based on the levels
of RNA degradation. Thus, while standardized RNA quality metrics such as the Degradometer [41] or
the RNA Integrity Number (RIN) [42], provide well-defined empirical methods to assess and compare
sample quality, there is no widely accepted criterion for sample inclusion. First, the most common
approach is to exclude from further analyses RNA samples with evidence of substantial degradation;
this approach relies on establishing an arbitrary cut-off value for establishing the samples’ quality.
Second, in case the decay of RNA is comparable, variation in gene expression estimates could be
corrected by applying standard normalization procedures. Third, if transcripts decay at different
rates, and if these rates are consistent across samples for a given level of RNA degradation, a model
that takes into consideration measured, sample-specific, degradation levels could be applied to gene
expression data to correct for the confounding effects of degradation [43].
Therefore, the first step for an accurate analysis of sequencing-based transcriptomics data
is the quality check of the raw reads. This step is necessary in order to highlight biases and/or
library contamination possibly occurred during the library preparation or sequencing procedure.
One of the most widespread software to perform a quality check of the raw reads is FastQC (https:
//www.bioinformatics.babraham.ac.uk/projects/fastqc/). Such software is nowadays employed in
the analysis of data obtained by Illumina platforms, but it was previously used also to analyse data
produced from Roche 454 and Solid platforms. FastQC allows multi-sample analysis and provides a
user-friendly and easy-to-use graphical interface. Beyond a general overview of the analysed sets of
reads, reporting information like the number of reads in the considered file, their length and percentage
of GC dinucleotides, the software shows the per-base quality of the entire set of reads. The quality is
measured through the Phred score, expressed by the following formula:
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q = −10 × log10(p)
where p indicates the error base-calling probability [44]. In general, if the Phred score of the 3’ bases
of the reads is beyond a certain threshold (typically 20), it is a good practice to “trim” the reads in
order to achieve an acceptable quality along all the sequence. The most common reads trimmers
are Cutadapt [45], TrimGalore (http://www.bioinformatics.babraham.ac.uk/projects/trim_galore/)
and the FASTX toolkit (http://hannonlab.cshl.edu/fastx_toolkit/). Such software can be used to
both remove residual adapters used in the library construction and to trim the low-quality bases.
Furthermore, FastQC provides information about the presence of contamination of the samples
(e.g., unbalanced GC content in respect of the organism under study), presence of non-detected bases
along with the reads, and overrepresented sequences.
3.2. Reads Alignment
The subsequent step is the alignment of the RNA-Seq reads onto a reference genome, in order to
assign each of the sequenced reads to a specific location on the genome/transcriptome. This procedure is
extremely challenging from a computational point of view. First, a number of reads that spans between
a few millions to hundred millions undergoes alignment on a reference genome, whose dimension,
in human, is around 3 billions base pairs. Moreover, since transcripts in eukaryotic genomes contain not
contiguous regions (e.g., introns), alignment tools for RNA-Seq reads should handle spliced alignment
with very large gaps. Therefore, Trapnell and colleagues [46] developed a splice-aware algorithm able
to align sequencing reads to a reference genome accurately, in a reasonable time and without relying on
known splice sites. This algorithm revolutionized the way of mapping sequencing reads to a genome
since it was the first one able to detect de novo splicing junctions, aligning reads towards non-contiguous
regions of the genome [47]. This feature boosted the discovery of non-annotated transcripts and novel
splicing isoforms. Later, since the technological development led to the production of longer and paired
reads, the same research group reported several improvements to the TopHat algorithm, developing
TopHat2 [48]. Specifically, TopHat2 maps the reads in two steps: (1) the software aligns first the reads
toward a reference transcriptome and (2) it maps the unmapped reads from the first step to the entire
reference genome. This approach not only allows to improve the reads mapping over small insertions
and deletions, but also to deal in a better way with processed pseudogenes. In addition, TopHat2
implements a fusion-detecting algorithm able to detect fusion transcripts deriving from translocation
events and from big insertions and deletions. Meanwhile, the sequencing throughput and read lengths
have significantly increased to several million reads per sample with lengths of hundreds of base pairs.
More recently, Pertea and colleagues, developed the so-called “Tuxedo 2” pipeline [49], which fully
addresses the challenges posed by the current technologies. The Tuxedo 2 pipeline integrates reliable
software which allows a reads’ mapping step, transcript assembling and differential expression analysis.
To map paired-end reads which are long at least 75–100 bp, we suggest using the HISAT2 algorithm.
Briefly, the HISAT2 developers designed an efficient and innovative indexing method of the genome, an
extension of the well-known Burrow-Wheeler Transform (BWT), named Graph-based FM index (GFM)
which ideally allows to align sequencing reads against a genome representative of the general human
population as well as against a single reference genome. Additionally, HISAT2 utilizes a large set of local
indexes covering genomic regions of 56 kilobases (https://ccb.jhu.edu/software/hisat2/index.shtml).
This novel approach may be definitely considered a current gold standard in the processing of the Next
Generation Sequencing (NGS) reads in current and upcoming toxicogenomics experiments.
3.3. Raw Counts Extraction
Once the read mapping is accomplished, it is crucial to assign the mapped reads to certain
genomic features (i.e., genes or exons). Since this task is aimed at the quantification of gene/transcript
wise expression, the choice of the annotation is important. Nowadays, plenty of different annotations,
produced by different consortia, are available. Such annotations are rapidly evolving as novel
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transcripts and splice isoforms are discovered and validated [50]. As a consequence, the user may
find the choice of a proper annotation quite dispersive. In fact, based on the specific needings
of the user, one may have to choose between narrow but well-curated annotations as well as the
NCBI Reference Sequence collection (RefSeq [51]). RefSeq provides a reliable genomic annotation,
continuously curated from the staff that includes automated computational methods, collaboration,
and manual data review. On the other hand, Ensembl (http://www.ensembl.org) and GENCODE
(https://www.gencodegenes.org) provide more comprehensive and updated annotations. Ensembl
includes automatically annotated entries, while GENCODE derives from merging the Ensembl
automatically annotated entries and the manually curated entries reported by the HAVANA team of
the Wellcome Trust Sanger Institute from the Vega database [52].
Since the transcriptome analysis in a toxicogenomics setting is aimed at the study of gene expression
deregulation upon the exposure of a certain compound on a biological system, a correct quantification
of gene expression is crucial. In this step, the aligned raw reads are summarized into a count matrix
which can be used for differential expression analysis [53]. The count matrix usually reports genes (or
more in general the genomic features of interest) in rows and samples in columns. HTSeq [54] is among
the most utilized algorithms developed until now for gene and transcript expression quantification.
HTSeq is a package developed in Python language which offers a suite of functionalities for the parsing
and the analysis of high-throughput sequencing data. However, the construction of reproducible and
solid analysis workflows often imposes the researchers to consistently perform all the steps in the R
environment. A clever solution for this restraint could be the employment of the Bioconductor Rsubread
package [53]. This package implements functions for several steps of the preprocessing of NGS reads, as
well as the alignment and reads summarization. Hereby, we suggest using it, especially for this second
functionality, through the featureCounts function. Moreover, for more specific purposes, Rsubread
allows the summarization of the reads by exon and splice junction rather than by gene, in order to
inspect the exon usage and, for instance, alternative splicing [53].
3.4. Normalization and Filtering
In order to carry out a reliable downstream analysis, as well as differential expression and
functional annotation of transcriptome data, the samples need to undergo normalization and filtering
steps. The former is needed since the transcript quantification step is directly dependent on the length
of the transcripts and the library size, in order to make comparable (1) the expression levels among the
transcripts of the same sample, (2) the sequenced samples between each other. The latter is aimed at
removing the low read counts since they correspond to the irrelevant biological features. Regarding
the normalization of RNA-Seq data, the classical and most widespread method is the Reads per
Kilobase of exon model per Million mapped reads (RPKM) [55]. This method performs a double-step
normalization. In fact, it allows a “within sample” normalization, scaling the read count value of
each transcript on the base of the length (expressed in kilobases) of that transcript. At the same time,
the RPKM method performs a “between samples” normalization correcting the read counts on the
base of the library size [56]. For the paired-end reads, the algorithm takes the name of Fragments
per Kilobase of exon model per Million mapped reads (FPKM) since it considers the fragment (both
pairs) rather than the single read. Although many other read counts normalization methods arose in
the last years, the RPKM/FPKM method is still one of the most largely employed in transcriptomics.
In 2010, Bullard and colleagues demonstrated that the differential expression evaluated after a per-lane
normalization (as for RPKM/FPKM) may be heavily biased by a small proportion of highly expressed
features. To overcome this limitation, they proposed a new normalization method [57] which scales
the read counts by the upper quantile of the counts distribution (UQUA), after filtering out the
genes whose read counts are significantly low in all the samples. In fact, after the read counts have
been normalized and made comparable across samples, it’s important to filter out the low or zero
read counts. Genes which are not expressed in any of the analysed conditions not only generate
an uninformative signal but also weaken the sensitivity in differentially expressed genes detection.
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By filtering low counts genes, will enrich for true differential expression while simultaneously reducing
the number of hypotheses tested, making, as a consequence, multiple testing adjustment less severe
[58]. Therefore, we strongly suggest to filter out the low (or non-) expressed features prior testing for
differential expression in order to achieve a more robust statistical significance.
3.5. Batch Effect Estimation and Correction
As for hybridization based experiments, also high-throughput sequencing experiments may
suffer from non-biological sources of variation. As already mentioned for the microarrays, Principal
Component Analysis (PCA) can be a precious instrument in order to identify the features affected by
batch surrogates. Principal components are able to capture both biological and technical variability
and, when estimated after the biological variables have been taken into account, it is able to quantify
the effects of artefacts in the data [30]. The above mentioned SVA Bioconductor package can be
used to identify and estimate surrogate variables for unknown sources of variation [29] also in NGS
experiments. In particular, the package SVA implements the svaseq function, which takes into account
the different statistical distribution of NGS data in respect of microarrays. However, the widely used
R packages edgeR [59] and DESeq2 [60] allow the user to correct for known unwanted variation
by including the batch variables in the design formula. In order to detect and remove unwanted
variation from high-throughput sequencing experiments, Risso and colleagues developed a method
named RUVSeq [61], which allows to normalize the read counts and to adjust for nuisance technical
effects at the same time. This method has been included in the homonym Bioconductor package and
it implements some strategies already employed for the batch effect removal in microarray [62–64].
Specifically, RUVSeq can employ three different approaches in order to normalize the data and identify
the factors of unwanted variation: (1) it can use negative control genes, such as genes which do not vary
across the samples on the base of the biological conditions of interest, or (2) negative control samples
for which the covariates of interest are constant; yet, (3) it can use residuals from a GLM analysis
performed on the unnormalized counts. Therefore, we suggest employing this counts’ normalization
strategy, especially in the cases where the unwanted variation factors are unknown.
4. Single Cell RNA-seq
scRNA-seq technologies became more widespread and provided unprecedented opportunities for
exploring gene expression profiles at single cell resolution, which greatly revolutionizes transcriptomic
studies. Since the first publication about scRNA-seq methodology in 2009 [65], a number of scRNA-seq
data analysis tools have been developed [66], that are available as scRNA-tools database (www.scRNA-
tools.org) [67]. Nonetheless, the golden standard pipelines have not yet been established due to the
technical noise, biological variation, the growing number of analysis methods and exploding data
set sizes. Although some pipelines, such as Cell Ranger [68], inDrops [69], SEQC [70] and zUMIs
[71] were proposed for the analysis of scRNA-seq data, they remain unexploited in most of the
cases. In the sections below, we will discuss currently available methods for data preprocessing and
analysis of scRNA-seq data. The common pipeline of scRNA-seq preprocessing is shown in Figure 4,
which comprises the following steps: quality check on raw sequencing data, alignment, read counts
extraction, cell quality check, normalization and data correction.
Since both bulk RNA-seq and scRNA-seq generally sequence transcripts into reads to generate the
raw data in .fastq format, and the scRNA-seq data are often structurally identical to bulk RNA-seq data,
the principles and methods used for data preprocessing of bulk RNA-seq, perhaps slightly modified,
can be employed in most of the steps of scRNA-seq data preprocessing. For this reason, we will focus
on analytical procedures which are specific for scRNA-Seq.
In scRNA-seq, one of the key challenges is to identify and remove low-quality cells that are damaged,
dead or mixed with multiple cells. Typically, cell-level QC metrics are used to remove problematic
cells. After cell QC, normalization is carried out for accurate comparisons of a gene’s expression across
samples. Normalization methods developed for bulk RNA-seq are often used for scRNA-seq data.
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However, their suitability with respect to scRNA-seq data is still unexplored. For normalization of
scRNA-seq data, several methods such as SCnorm [72] and Scran [73] have been recently proposed.
SCnorm uses quantile regression to estimate the dependence of read counts on sequencing depth for
every gene. Scran uses the summed expression values across pools of cells to conduct normalization.
Log(x + 1) transformation was recommended to examine log-fold changes in expression, mitigate the
mean-variance relationship and reduce the skewness of the data after normalization.












Figure 4. Data preprocessing schema for single-cell RNA-Seq. The brown box indicates the input of
the pipeline. The green box indicates the output of the pipeline. The blue boxes show the intermediate
steps of the pipeline and above or below the boxes are shown the software/packages employed in
the step.
Among steps in the data preprocessing pipeline for scRNA-seq, data correction aims to remove
technical, biological and batch effects. The technical and biological effects can be regressed out by a
simple or variant of regression model. Several methods to mitigate the batch effects in scRNA-seq
data, such as Mutual Nearest Neighbor (MNN) and K-nearest neighbor Batch Effect Test (KBET),
were proposed. From a recent comparison of classical batch effect correction methods [74], Combat [31]
was confirmed to perform well. After read counts (also called expression quantification), digital gene
expression matrices have the dimension of the number of barcodes (cell) multiplied by the number of
transcripts (gene). The raw expression matrices often include over 20,000 genes. Because scRNA-seq
experiments generate a portion of low-quality data from damaged or dead cells, cell quality check
(QC) must be performed to ensure all cellular barcode data correspond to viable cells before
downstream analysis.
4.1. Cell Quality Check
To exclude the low-quality data, which makes the downstream analysis difficult and may lead
to misinterpretation, a series of QC analyses is required to ensure that the data quality is sufficient
for downstream analysis. Three covariates are used for the QC: the number of counts per barcode
(count depth), the number of genes per barcode, and the fraction of counts from mitochondrial genes
per barcode [75,76]. The low-quality cells whose membranes are broken or doublets are discarded
by examination of the distribution of the QC covariates. Cytoplasmic RNAs are usually lost but
mitochondrial RNAs are retained for broken cells, thus barcodes (cells) with a low count depth,
few detected genes, and a high fraction of mitochondria counts are indicative of low-quality cells.
Cells with unexpectedly high counts and a large number of detected genes may represent doublets,
which are artifactual libraries generated from two cells and can lead to spurious biological conclusions.
The high-count depth threshold can be used to exclude doublets. In addition, computational doublet
detection tools (e.g., DoubletFinder) based on gene expression features can be used [77]. Since there
are no specific threshold values for the QC covariates, it may be necessary to revisit quality control
decisions multiple times when analyzing the data [78].
4.2. Feature Selection and Visualization
Human scRNA-seq data are high dimensional since they measure expression levels of thousands
of genes (up to 25,000) in a large number of cells. Feature selection is a key step in many single-cell
RNA-seq analyses to keep only genes that are informative of the variability in the single-cell RNA-seq
data. Highly Variable Genes (HVGs) method [79], which relies on the assumption that the genes
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with highly variable expression across cells are resulted from biological effects rather than technical
noise, is often used. Typically, between 1000 and 5000 HVGs are selected for downstream analysis.
Further, scRNA-seq data visualization can be performed in four main steps: normalization, feature
selection (HVGs), dimensionality reduction with principal components analysis (PCA), and projection
of scRNA-seq data in an embedded space such as T-distributed Stochastic Neighbor Embedding
(t-SNE) and Uniform Manifold Approximation and Projection (UMAP). Typically, PCA identifies the
directions of the top N principal components and transforms the data in the low dimension space.
Each component is used to infer which genes are contributing the most to variance in the population
and are involved in differentiating cells’ subpopulations. The number of N principal components can
be determined by “elbow” heuristics or the permutation-test-based jackstraw method. t-SNE is a way
of converting a high-dimensional data set into a matrix of pair-wise similarities. This technique reveals
the local structure of the high-dimensional data, while also discloses the global structure such as the
presence of clusters at several scales [80]. Briefly, the algorithm projects the data points on the 2D plane,
initially at random positions, and lets them interact as if they were physical particles. The interaction
is governed by two laws: first, all points are repelled from each other; second, each point is attracted
to its nearest neighbours, allowing, in this way, the clustering of data points that are actually more
similar from the transcriptional point of view [81]. However, t-SNE suffers from several limitations
such as loss of the intercluster relationships, slow computation time and weak reproducibility in
representing very large datasets. On the contrary, UMAP, was confirmed to provide faster run times,
higher reproducibility on big datasets and meaningful organization of cell clusters [82].
4.2.1. Cell Type Identification and Population Analysis
A common data analysis pipeline for scRNA-seq data includes the identification of distinct cell
types to unravel the cellular heterogeneity of samples. The identification should be carried out after
QC and normalization. This task is typically solved by unsupervised clustering methods and manual
annotation based on canonical gene markers (e.g., genes associated with a cluster of differentiation
(CD) markers in the immune cells). The clustering algorithms specialized for the scRNA-seq data are
generally declined from some type of general k-mean, graph-based, density-based, or hierarchical
clustering. The cells are grouped into clusters based on the similarity of their gene expression profiles.
After clustering, the gene markers are used to characterize and annotate the clusters with a meaningful
biological label. Since the manual annotation is a time-consuming process and not reproducible
across different experiments within and across research groups, a growing number of classification
approaches based on machine learning algorithms and artificial neural networks are being adapted
to automatically label cells. Recently, twenty-two automatic cell type identification methods were
evaluated using 27 publicly available scRNA-seq data sets of different sizes, technologies, species,
and levels of complexity [83]. In the evaluation, general-purpose SVM rejection classifier (with a linear
kernel) provided the best performance across all data sets [84].
4.3. High-Throughput Transcriptomics
High-throughput transcriptomics technologies represent diverse technical solutions to increase the
throughput and reduce the cost of gene expression profiling, and frequently this includes measuring
less than the full genomic complement of genes. For descriptions of individual technologies, please refer
to the part I in this series of reviews. Preprocessing protocols can also be highly customized and
manufacturer specific, e.g., the L1000 technology [5]. In this case, preprocessed data or methods are
usually provided by the technology manufacturer or service provider as part of the service fee. But in
general if a sizable fraction of the whole transcriptome has been measured, e.g., from a few thousands to
the full genome such as with the S1500+ platform [85], the same methods can be used as for microarray
or RNA-seq analysis. Continuous data can be treated as microarray data and count-based as RNA-seq
data. Global normalization methods, such as RMA and especially LOWESS, can also be used with
lower numbers of genes [86]. If the number of measured genes is below the low hundreds or the gene
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complement is highly biased customized normalization methods are usually employed. These can
be similar to the methods used for qPCR arrays, e.g., standardization using house-keeping or other
invariant or least variant genes followed by an intensity-based correction [87,88]. High-throughput
technologies frequently have higher noise levels than standard established full-genome technologies,
so it may be advisable to analyse a larger number of biological replicates e.g., going from the
recommended three up to five or more. Although this negates part of the cost-savings, the cost
of the profiling per-sample can still be an order of magnitude less than with conventional technologies.
5. Differential Expression Analysis
A gene is considered to be differentially expressed if the difference between its expression
measured in two experimental conditions is statistically significant. For microarray experiments,
differential expression analysis can be performed in R by using the limma package [32]. Limma uses
linear models to estimate the covariate dependencies between samples and the variability in the data
set. Indeed, the lmFit function from the limma package fits gene-wise linear models to the microarray
data. The user defines the design for the model by providing the biological variable of interest and
covariates (biological and technical batch variables). Since the variability in the expression matrix
can be due both to biological and technical variables, as discussed above, it is important to include
as covariates of the limma model the batch effect variables that have been used in the batch removal
step. The contrasts of interest are then specified to obtain contrast specific coefficients from the linear
model. The eBayes function is applied to assess differential expression by using the fitted model with
the contrast coefficients. Furthermore, an adjustment method for the p-values is applied to avoid
errors given by the multiple testing procedure. The classical approach to control for multiple testing
is by familywise error rate (FWER), which focuses on avoiding the Type I errors (‘false positives’) in
a very strict way. Examples of methodologies that fall into this category are the Bonferroni method
and its variant Holm’s method [89], as well as Hommel [90], and Hochberg methods [91] respectively,
with the first two having the advantage that no assumption on the dependence structure of p-values is
made. However, the aforementioned procedures have been proven to be overconservative for many
applications of genomics. Nowadays, the most popular method for multiple testing adjustment is
the one developed by Benjamini and Hochberg [92], which controls the false discovery rate (FDR).
FDR is much less conservative and addresses the proportion of the ‘false positives’ or ‘false discoveries’
in the selected set of differentially expressed genes, which is advantageous in exploratory genomic
analyses [93,94]. Final reporting of the differentially expressed genes is performed by using the toptable
function.This analysis gives in output for every gene a fold change, that explains how different is
the gene expression value between the conditions, and a p-value that explains how significant is that
difference. The user may set up a threshold on the p-value and fold-change to identify the final set of
differentially expressed genes.
The limma package works well also with RNA-Seq experiments, with few adjustments for this
data type. Indeed, limma transforms the read counts matrix in log2-counts-per-million (logCPM) and
the mean variance relationship can be modelled with two different approaches: precision weights
and an empirical Bayes prior trend [95,96]. For the first case, limma implements the function voom,
which should be used in case the library sizes of the samples are quite variable, and, optionally, one can
apply a between-samples normalization (e.g., quantile). For homogeneous library sizes, the second
approach is preferred, and it can be employed through the argument trend in the eBayes function.
Similarly, edgeR [59,97] and DESeq2 [60] are two among the most used tools for differential expression
analysis. Their implementation and usage is quite similar, if not overlapping to the limma one.
The main difference is that they are specifically designed for Next Generation Sequencing analyses,
thus taking into account all the characteristics of this kind of data. Briefly, they fit a negative binomial
model prior to the multiple testing for differential expression. Both tools take in input unnormalized
read counts (although edgeR accepts also normalized counts), and calculate a normalization factor and
scale the counts accordingly. Finally, the NOISeq package [98] provides many useful tools in order
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to prepare the data and perform a differential expression analysis, such as (1) quality control of the
read counts, (2) counts normalization and filtering, and (3) multiple testing for differential expression.
NOISeq can take in input both normalized or unnormalized data and the applied test is non-parametric,
so no assumption on the data distribution is made for the analysis. NOISeq method was optimized
to compute differential expression on data with technical replicates. In case of biological replicates,
the authors developed the NOISeqBIO algorithm, which is, instead, optimized for this kind of setting.
Note that NOISeq also implements the NOISeq-sim algorithm, which can be useful in case no replicates
are available. NOISeq-sim simulates technical replicates from a multinomial distribution, however we
discourage the users from applying it for testing if the aim is a robust differential expression analysis.
6. Gene Functional Annotation and Pathway Analysis
The functional annotation of genes is an essential step to further interpret the results of
transcriptomics experiments. This analysis is usually performed in order to characterize the biological
role of a certain gene of interest (e.g., differentially expressed genes) in the cell, as well as its
activity in one or more molecular processes and its localization in the cell. The main functional
annotation databases are the Kyoto Encyclopedia of Genes and Genomes (KEGG) pathways [99],
Reactome pathways [100], Gene Ontology terms [101] (GO) and WikiPathways [102]. All these
databases collect lists of genes categorized by different criteria. Functional annotation allows the user
to study the distribution of sets of genes in the different annotated categories.
Gene overlap or over-representation analysis with the Fisher’s exact test is the most commonly
used statistical method. P-values represent the difference between the observed and the expected
overlaps between the differentially expressed genes in the experiment and the functional gene set,
as well as the numbers of genes involved. Multiple testing correction is performed to control for
spurious results. However, as the Fisher’s exact test assumes that differential expression of one gene
does not depend on the others (no inter-gene correlations), the test can give nonspecific results with
long gene lists. Variants of the classical Fisher’s exact test implemented in e.g., the topGO-package can
mitigate nonspecific results from large gene sets at the top of the GO-hierarchy by taking advantage of
the dependencies in the directed-acyclic graph structure of the database [103].
Gene Set Enrichment Analysis (GSEA), which is also referred to as functional class scoring,
is a rank-based threshold-free method that does not rely on differentially expressed genes to perform
pathway analyses but uses all available gene expression information [104–106]. The benefits of the
method include the fact that it operates at pathway level and thus, considers biological complexity,
by allowing inclusion of low-level changes that may not be detected in traditional analyses aimed at
identifying differentially expressed genes. The method avoids the use of arbitrary fold-change and
p-value limits, which may be one of the biggest obstacles towards implementation of standardized
bioinformatics pipelines in toxicogenomic approaches [107]. Large numbers of GSEA methods exist
that give somewhat different results and test for different hypotheses [108]. To avoid nonspecific
results, methods that incorporate sample permutation or rotation are used, such as the limma ROAST,
ROMER or the Broad Institute GSEA method with sample permutations [32,104]. Large numbers of
permutations or rotations may be needed as the minimum two-sided p-value is 1/(nrot+ 1), where nrot
is the number of the permutation or rotation steps (p-values of zero are especially detrimental).
Parametric methods can also be used and may have higher sensitivity, as long as they consider
inter-gene correlations, such as the limma CAMERA method [32]. Overall, for smaller-scale analyses,
the Broad Institute GSEA tool is a good choice. Annotating results from omics experiments into
functional categories is essential not only to understand the underlying regulatory dynamics but also
to compare multiple experimental conditions at a higher level of abstraction.
Programmatic larger-scale analyses can be performed with the methods in the limma R package.
R and Cytoscape-based workflows can also combine visualizations with pathway analyses in a very
powerful manner [109,110]. Fisher’s exact test based methods can be used if there are no other
alternatives, especially for GO analyses, although packages such as the topGO are preferable in
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that case. Furthermore, a multitude of tools are available to the community to graphically represent
enriched functional annotations from single pairwise comparisons such as g:Profiler [111], DAVID [112],
ToppGene Suite [113], Enrichr [114]. These tools have a nice graphical interface to visualize the results,
but they allow the user to analyze one experiment at a time, while comparisons between different
runs have to be performed manually. Some other tools have been proposed that are able to compare
different experimental conditions at the same time, such as clusterProfiler [115] and BACA [116].
However, they require a certain programming ability in order to produce the desired visualizations.
Thus, using these tools is quite complex as the number of experiments to compare increases.
Since more and more toxicogenomics studies involve the comparison of the effect of
different materials at the same time, we recently proposed a graphical tool implemented in R,
called FunMappOne [110], that enables the users to graphically inspect, navigate, and compare
functional annotations in multiple experiments at different levels of abstraction. This tool facilitates the
analyses of multiple experimental conditions through a simple user interface and dynamic graphical
representations of the relevant functional categories.
7. Conclusions
The newly flourished TGx field is lacking rational guidelines for the preprocessing of large scale
data deriving from transcriptomics experiments. Addressing this drawback is crucial in order to carry
out reliable risk assessment and toxicity prediction. A proper setting of the data preprocessing assures
a robust outcome from the downstream analysis, and, in turn, allows to correctly answer the biological
questions posed by the study. For this reason, it is important to highlight that the outcome of the
analysis, such as the degree of toxicity of a chemical, often depends on thresholds or parameters of
algorithms set in all the analytical steps. Thus, particular attention must be paid to these aspects to
perform a thoughtful final decision.
In this review, which is the second part of a three papers series, we outlined the best practices in the
preprocessing of transcriptomics data derived from DNA microarray, bulk RNA-Seq and scRNA-Seq
technologies, and we make them available to the TGx community. Since the batch effect evaluation step
is not often considered in the routine analytical practice, we pointed out the most widespread methods
and procedures to evaluate and, eventually, correct the data from technical variability. Moreover,
we covered the golden standard methods to perform basic steps of the downstream analysis, including
differential expression analysis and gene functional annotation. In conclusion, this review article
represents a reference survey of “good practices” for transcriptomics data analysis in TGx.
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Abbreviations
The following abbreviations are used in this manuscript:
AGA Automated Genomics Analysis
BACA Bubble Chart to Compare Biological Annotations
BWT Burrow-Wheeler Transform
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CAMERA Correlation Adjusted MEan RAnk gene set test
CD Cluster of Differentiation
CDF Chip Description File
CEL-Seq Cell Expression by Linear amplification and Sequencing
CMAP Connectivity Map
DAVID Database for Annotation, Visualization and Integrated Discovery
Drop-seq Droplet sequencing
ENMs Engineered Nanomaterials
eUTOPIA solUTion for Omics data PreprocessIng and Analysis
FDR False Discovery Rate
FPKM Fragments Per Kilobase of exon model per Million mapped reads
FWER Family-Wise Error Rate
GEO Gene Expression Omnibus
GFM Graph-based FM index
GLM Generalized Linear Models
GO Gene Ontology
GSEA Gene Set Enrichment Analysis
HISAT2 Hierarchical Indexing for Spliced Alignment of Transcripts 2
HVGs Highly Variable Genes
KBET K-nearest neighbor Batch Effect Test
KEGG Kyoto Encyclopedia of Genes and Genomes
L1000 Library of Integrated Network-based Cellular Signatures 1000
logCPM log2-Counts Per Million
LOWESS LOcally WEighted Scatterplot Smoothing
MARS-seq MAssively parallel single-cell RNA-Sequencing
MeV MultiExperiment Viewer
MNN Mutual Nearest Neighbor
NCBI National Center for Biotechnology Information
NGS Next Generation Sequencing
Open TG-GATEs ToxicoGenomics project-Genomics Assisted Toxicity Evaluation system
PCA Principal Component Analysis
QC Quality Check
RefSeq Reference Sequence collection
RIN RNA Integrity Number
RNA-seq RNA sequencing
ROAST ROtAtion Gene Set Tests
ROMER ROtation testing using MEan Ranks
RPKM Reads Per Kilobase of exon model per Million mapped reads
RSEM RNA-Seq by Expectation Maximization
SAVER Single-cell Analysis Via Expression Recovery
scRNA-seq single cell RNA sequencing
SEQC Sequence Quality Control
SVA Surrogate Variable Analysis
SVM Support Vector Machine
TGx ToxicoGenomics
t-SNE t-distributed Stochastic Neighbor Embedding
UMAP Uniform Manifold Approximation and Projection
UMI Unique Molecular Identifiers
UQUA Upper Quantile
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